MEDICA consultation with Italian company A Pump and ACPI offer & US company P's EZ Regular re-contract offer

Italian company A, which consulted at MEDICA, an international medical device exhibition in Germany, is asking for details on supply to sell equipment and consumables related to anticancer drugs to the Italian market.

This company has been marketed as an analog-level technology product, but it offers Anyfusion's innovative technology to be marketable with improved competitiveness. I will share the specific amount of negotiation and the details of the negotiation.

Company p in the United States requested annual sales volume to discuss the details of the request for the supply price for EZ regular sales.

We would also like to proceed with negotiations to supply Anyfusion and ACPi first when we resume business with US company P. We have already provided considerable information about Anyfusion, and we are constantly interested in the product structure that P company sells by strengthening the same market competitiveness as the product area we developed. We would like to complete and supply negotiations with them before FDA certification is completed.

Spanish partners have informed the Spanish market that they are doing their best, though not smooth, due to Corona, in negotiations with major U.S. companies for exclusive supply and visits to EZ Regular, Anyfusion pump and ACPI launching. Last week, the Spanish government reported that quarantine has eased one step and has promised a meeting with an authoritative cancer professor at the Barcelona Hospital to introduce the product.

We are preparing for management that minimizes the size of the product with the goal of post-COVID-19 under a lot of control over our business activities at domestic and abroad, and we are doing our best to improve the completeness of the product. In Korea, Anyfusion sales are being promoted to several general hospitals, and NICU demo in many university hospitals is steadily progressing, so we will proceed with the purchase work delayed due to COVID-19 in stages in connection with quarantine.

Thank you.